MedTrace Logo

Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes

NCT07075796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-01-13

No results posted yet for this study

Summary

This study is a prospective, single center, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE in patients with diabetes type 2 and how the accuracy of the system improves as the time of use by the patient increases.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DEVICE

GLUCUBE system

A non-invasive system to monitor and measure the blood glucose compared to the standard glucometer in a group subjects

Sponsors & Collaborators

  • iGluco

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-02
Primary Completion
2025-11-28
Completion
2025-11-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07075796 on ClinicalTrials.gov